82 related articles for article (PubMed ID: 18523160)
1. Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia.
Yau L; Molnar P; Moon MC; Buhay S; Werner JP; Molnar K; Saward L; Del Rizzo D; Zahradka P
J Pharmacol Exp Ther; 2008 Sep; 326(3):717-24. PubMed ID: 18523160
[TBL] [Abstract][Full Text] [Related]
2. MIBG, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents differentiation of L6 skeletal myoblasts by inhibiting expression of myogenin and p21(cip1).
Yau L; Litchie B; Zahradka P
Exp Cell Res; 2004 Dec; 301(2):320-30. PubMed ID: 15530866
[TBL] [Abstract][Full Text] [Related]
3. Target proteins for arginine-specific mono(ADP-ribosyl) transferase in membrane fractions from chick skeletal muscle cells.
Huang HY; Zhou H; Huiatt TW; Graves DJ
Exp Cell Res; 1996 Jul; 226(1):147-53. PubMed ID: 8660950
[TBL] [Abstract][Full Text] [Related]
4. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
Moon MC; Molnar K; Yau L; Zahradka P
J Vasc Surg; 2004 Jul; 40(1):130-7. PubMed ID: 15218473
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase inhibition combined with irradiation: a dual treatment concept to prevent neointimal hyperplasia after endarterectomy.
Beller CJ; Kosse J; Radovits T; Gerö D; Krempien R; Gross ML; Berger I; Hagl S; Szabó C; Szabó G
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):867-75. PubMed ID: 17011459
[TBL] [Abstract][Full Text] [Related]
6. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase.
Yau L; Elliot T; Lalonde C; Zahradka P
Eur J Biochem; 1998 Apr; 253(1):91-100. PubMed ID: 9578465
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mono-ADP-ribosyltransferase activity during the execution phase of apoptosis prevents apoptotic body formation.
Lodhi IJ; Clift RE; Omann GM; Sweeney JF; McMahon KK; Hinshaw DB
Arch Biochem Biophys; 2001 Mar; 387(1):66-77. PubMed ID: 11368185
[TBL] [Abstract][Full Text] [Related]
8. Effect of an arginine-specific ADP-ribosyltransferase inhibitor on differentiation of embryonic chick skeletal muscle cells in culture.
Kharadia SV; Huiatt TW; Huang HY; Peterson JE; Graves DJ
Exp Cell Res; 1992 Jul; 201(1):33-42. PubMed ID: 1612127
[TBL] [Abstract][Full Text] [Related]
9. Intracellular inhibition of mono(ADP-ribosylation) by meta-iodobenzylguanidine: specificity, intracellular concentration and effects on glucocorticoid-mediated cell lysis.
Smets LA; Loesberg C; Janssen M; Van Rooij H
Biochim Biophys Acta; 1990 Aug; 1054(1):49-55. PubMed ID: 2143421
[TBL] [Abstract][Full Text] [Related]
10. Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation).
Loesberg C; van Rooij H; Smets LA
Biochim Biophys Acta; 1990 Jan; 1037(1):92-9. PubMed ID: 2104758
[TBL] [Abstract][Full Text] [Related]
11. Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression.
Yau L; Litchie B; Thomas S; Storie B; Yurkova N; Zahradka P
Eur J Biochem; 2003 Jan; 270(1):101-10. PubMed ID: 12492480
[TBL] [Abstract][Full Text] [Related]
12. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma.
Tang Y; Wang YL; Yang L; Xu JX; Xiong W; Xiao M; Li M
Int J Mol Med; 2013 Jul; 32(1):130-6. PubMed ID: 23652727
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinase inhibition by batimastat does not reduce neointimal thickening in stented atherosclerotic porcine femoral arteries.
van Beusekom HM; Post MJ; Whelan DM; de Smet BJ; Duncker DJ; van der Giessen WJ
Cardiovasc Radiat Med; 2003; 4(4):186-91. PubMed ID: 15321056
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterisation of a fungal mono(ADP-ribosyl)transferase.
Deveze-Alvarez M; García-Soto J; Martínez-Cadena G
Adv Exp Med Biol; 1997; 419():155-62. PubMed ID: 9193648
[TBL] [Abstract][Full Text] [Related]
16. Vascular cell kinetics in response to intimal injury ex vivo.
Tigerstedt NM; Savolainen-Peltonen H; Lehti S; Hayry P
J Vasc Res; 2010; 47(1):35-44. PubMed ID: 19672106
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
Kitada K; Yui N; Matsumoto C; Mori T; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2009 Dec; 331(3):998-1004. PubMed ID: 19737855
[TBL] [Abstract][Full Text] [Related]
18. Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells.
Del Vecchio M; Balducci E
Mol Cell Biochem; 2008 Mar; 310(1-2):77-83. PubMed ID: 18066713
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants involved in the increase of damage-induced apoptosis and delay of secondary necrosis due to inhibition of mono(ADP-ribosyl)ation.
Cerella C; Mearelli C; Ammendola S; De Nicola M; D'Alessio M; Magrini A; Bergamaschi A; Ghibelli L
Ann N Y Acad Sci; 2006 Dec; 1090():50-8. PubMed ID: 17384246
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.
Banasik M; Komura H; Shimoyama M; Ueda K
J Biol Chem; 1992 Jan; 267(3):1569-75. PubMed ID: 1530940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
